Eli Lilly said to be in talks to buy Scorpion Therapeutics for $2.5B
Eli Lilly and Company is in advanced talks to acquire biotechnology company Scorpion Therapeutics for $2.5 billion, the Financial Times reported on Friday, citing people briefed on the negotiations. A…
